Use the toggle to switch between the simple Overview and the Technical Data content.
Pantothenic Acid (Vitamin B5): A Plain-English Guide
Overview
Plain-English information for everyday use
1. What Is Pantothenic Acid?
💡
Key Takeaway
Pantothenic acid is Vitamin B5 — your body uses it to make Coenzyme A, a molecule that helps turn food into energy and supports the building blocks of fats, hormones, and skin.
Pantothenic acid is a water-soluble B-complex vitamin — Vitamin B5. The name comes from the Greek word pantos, meaning "from everywhere," because it is found in nearly every food we eat. NIH Office of Dietary Supplements. Pantothenic Acid Health Professional Fact Sheet. View source ↗
Inside your cells, pantothenic acid gets built into Coenzyme A (CoA) — a small carrier molecule your body uses for energy production from carbohydrates, fats, and proteins. CoA is involved in dozens of everyday metabolic steps. Pantothenic acid is also a building block of the 4'-phosphopantetheine arm of Acyl Carrier Protein, the cellular machinery that assembles new fatty acids. Sanvictores T, Chauhan S. Vitamin B5 (Pantothenic Acid). StatPearls. View source ↗
Three supplemental forms appear on store shelves, and they are not interchangeable. Calcium pantothenate is the standard oral form in most multivitamins and B-complexes. Pantethine is the disulfide form, which the body converts into cysteamine inside cells — and the form most studied for lipid hemodynamic support. Dexpanthenol is the alcohol form used in many topical skin and hair products, where it converts to pantothenic acid on contact with tissue. McCarty MF. Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine. Medical Hypotheses. View source ↗
Key Highlights
Water-soluble B-complex vitamin (Vitamin B5)
The precursor to Coenzyme A, central to everyday metabolism
Found in nearly every food — meat, eggs, dairy, whole grains, legumes
Three supplemental forms: calcium pantothenate, pantethine, and dexpanthenol
Friendly gut bacteria make small amounts, but food is the main source
2. Signs You May Be Running Low
💡
Key Takeaway
Low B5 is uncommon in healthy adults eating varied foods. The signs are vague — tiredness, irritability, sleep changes — and overlap with many other causes; discuss with your provider.
Pantothenic acid is everywhere in the food supply, so running low is uncommon in healthy adults. When low intake does happen, the signs are nonspecific and gentle rather than dramatic: NIH Office of Dietary Supplements. Pantothenic Acid Health Professional Fact Sheet. View source ↗
These signs can have many different causes — they are not specific to pantothenic acid alone, and reaching for any single nutrient before talking with your healthcare provider can mask a different problem that deserves a closer look.
3. Who Should Be Careful
💡
Key Takeaway
Most healthy adults handle B5 well at everyday amounts. Caution applies if you are pregnant or nursing, taking blood thinners, on certain antibiotics, or have a known PANK2 genetic variation.
Pantothenic acid has a strong safety profile at everyday food and supplement amounts. The watch-list below is for situations where checking with your healthcare provider before starting a higher-amount product (especially pantethine) is the safer choice. NIH ODS Pantothenic Acid Health Professional Fact Sheet. View source ↗
Pregnant or nursing — limited data at higher amounts; food and basic multivitamin amounts are well-tolerated
On blood thinners or antiplatelet products — pantethine may modestly affect platelet behavior; discuss before adding
Taking tetracycline antibiotics — pantothenic acid and tetracyclines bind to each other; separate by about two hours
Liver concerns — limited research at higher amounts; provider check is sensible
Recovering from bariatric procedures — your team will check overall nutrient status; B5 deficit after bariatric care is uncommon but worth tracking
Known PANK2 genetic variation — this requires specialist supervision, not a self-directed supplement choice Bokhari SRA. Pantothenate Kinase-Associated Neurodegeneration (PKAN). StatPearls. View source ↗
4. How to Get Best Results
💡
Key Takeaway
Take B5 with food. Pick the form that matches your goal — calcium pantothenate for everyday B-complex support, pantethine for lipid-pathway support, dexpanthenol topically for skin.
Pantothenic acid is water-soluble and absorbed reliably from food and supplements when taken with meals. A few practical tips: Vadlapudi AD et al. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. View source ↗
Take with food. Absorption is steady with meals; an empty stomach is fine but offers no advantage.
Choose the form for the goal. Calcium pantothenate is the most common everyday form. Pantethine is the form studied for lipid-pathway support and is typically split across the day. Dexpanthenol is the topical form found in skin and hair products — it converts to pantothenic acid where it is applied.
Split larger amounts across the day. If you and your provider settle on a higher amount of pantethine, twice- or three-times-daily dosing is gentler on the stomach than a single large dose.
Space from tetracyclines. If you take a tetracycline antibiotic, separate it from B5 by about two hours.
Give it weeks, not days. Lipid-pathway changes from pantethine emerge over weeks of consistent use, not overnight.
5. Side Effects
💡
Key Takeaway
B5 is among the better-tolerated B vitamins. Most people notice nothing. Mild stomach upset at higher amounts and rare skin reactions are the main reports.
Pantothenic acid has a strong tolerability record across the supplemental amounts used in everyday and higher-tier products. The Food and Nutrition Board has not set an Upper Limit for B5 because the data do not support one. Institute of Medicine (US). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. View source ↗
Mild stomach upset — occasional nausea or loose stools at higher amounts, especially on an empty stomach
Mild fatigue — sometimes reported with pantethine, despite B5 often being marketed for energy
Rare skin reactions — sparse reports of mild rash or itch with pantethine, mechanism not established
Mild liver-enzyme uptick — uncommon and not clearly attributable to B5 in head-to-head data
If you notice persistent symptoms after starting a higher-amount B5 product, pausing and talking with your healthcare provider is the right next step.
6. What Research Suggests
💡
Key Takeaway
Evidence is strongest for pantethine in lipid-pathway support (moderate), limited for skin-related pantothenic acid use, and early for the PANK2 specialist context.
The state of the evidence varies by form and by question. Where research is mature, the framing here states what science actually supports — without narrating any particular study's clinical-population result.
Pantethine and lipid-pathway support — Moderate, mature. Multiple randomized studies, plus a systematic review, examined pantethine's effect on cardiovascular-lipid biomarkers. Magnitude has varied by population baseline and background diet; effect direction is consistent across studies. Evans M et al. Pantethine, a derivative of vitamin B5, favorably alters cholesterol in low to moderate cardiovascular risk subjects. Vasc Health Risk Manag. View source ↗McRae MP. Pantethine systematic review of randomized clinical investigations. Nutr Res. View source ↗
High-amount calcium pantothenate and skin — Limited, early. A small randomized study examined pantothenic acid at high amounts for skin concerns; the evidence base remains a single positive study awaiting independent replication. Yang M et al. A randomized, double-blind, placebo-controlled study of a novel pantothenic acid-based dietary supplement in subjects with mild to moderate facial acne. Dermatol Ther. View source ↗
PANK2 genetic-variation context — Limited, investigational. A small pediatric pilot has studied pantethine as nutritional repletion under specialist supervision. The evidence is early. Chang X et al. Pilot trial of pantethine in children with PANK2 mutation-related disease. Orphanet J Rare Dis 2020. View source ↗
Athletic performance — Insufficient. Older small studies are null or inconsistent; modern data are sparse.
7. Top Food Sources
💡
Key Takeaway
Pantothenic acid is in nearly every food. Standouts include organ meats, mushrooms, sunflower seeds, eggs, salmon, avocado, and yogurt.
The name "pantothenic" means "from everywhere" — and the food story matches. Most varied diets cover everyday needs. Especially generous sources: USDA FoodData Central. View source ↗
Beef liver, chicken liver
Mushrooms (shiitake, portobello, white)
Sunflower seeds
Eggs (especially the yolk)
Salmon and trout
Avocado
Plain yogurt and milk
Sweet potato
Brown rice and oats
Lentils and chickpeas
Broccoli and cauliflower
Nutritional yeast
Daily Value (DV) = 5 mg/day for adults (FDA reference).
Food
Serving
Pantothenic Acid (mg)
% Daily Value
Beef liver, braised
3 oz
5.6
112%
Sunflower seeds, dry roasted
1/4 cup
2.4
48%
Shiitake mushrooms, cooked
1/2 cup
2.1
42%
Chicken breast, roasted
3 oz
1.3
26%
Avocado
1 medium
2.0
40%
Salmon, baked
3 oz
1.4
28%
Plain Greek yogurt
1 cup
1.4
28%
Eggs, large
1 large
0.7
14%
Sweet potato, baked
1 medium
1.0
20%
Lentils, cooked
1/2 cup
0.6
12%
Brown rice, cooked
1 cup
0.7
14%
Broccoli, cooked
1/2 cup
0.5
10%
Nutritional yeast, fortified
2 tbsp
10.0
200%
Cooking and food processing reduce the pantothenic acid content modestly — about 30 percent for typical cooking, more for highly refined products.
8. Body Systems Supported
💡
Key Takeaway
Coenzyme A — what your body makes from B5 — sits at the crossroads of energy metabolism, fat handling, skin renewal, and the nervous system's everyday signaling.
Because Coenzyme A is involved in so many everyday metabolic steps, pantothenic acid quietly supports a wide range of body systems:
Energy metabolism — central to the conversion of carbohydrates, fats, and proteins into the cellular energy currency (ATP) the rest of the body runs on
Lipid and fatty-acid handling — the 4'-phosphopantetheine arm built from B5 is the cellular machinery for building new fatty acids and shaping membrane composition
Skin and hair — supports normal sebum balance and barrier renewal; the topical dexpanthenol form is widely used in skin and hair products
Nervous system — supports normal acetylcholine signaling and neurotransmitter handling through CoA-dependent steps
Adrenal and stress homeostasis — historically nicknamed the "anti-stress vitamin" because adrenal hormone synthesis uses CoA-dependent steps; modern evidence frames this as routine biochemistry, not a stress remedy
Hepatic everyday support — many liver detoxification and acyl-transfer steps depend on CoA availability
9. Frequently Asked Questions
💡
Key Takeaway
Common questions about B5 — safety, forms, food vs. supplement, what makes pantethine different, and when professional input matters.
Is pantothenic acid safe to take every day?
Yes, at typical supplement amounts. The Food and Nutrition Board did not set an Upper Limit because the data do not support one. Most people tolerate B5 well. Higher amounts (pantethine in particular) call for a conversation with your provider, especially if you take other products. Institute of Medicine (US). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. View source ↗
What is the difference between pantothenic acid and pantethine?
They are related but not the same thing. Pantothenic acid (usually sold as calcium pantothenate) is the standard B5 form found in food and basic multivitamins. Pantethine is a different molecule — two pantothenamide units linked through cystamine — that the body converts into cysteamine inside cells. The cysteamine step is what gives pantethine its distinct effect on lipid-pathway biology, an effect that calcium pantothenate does not produce. McCarty MF. Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine. Medical Hypotheses. View source ↗
Can I get enough B5 from food alone?
For everyday baseline needs — yes, most varied diets cover B5 amply. Pantothenic acid is present in nearly every food, with especially generous amounts in liver, mushrooms, eggs, yogurt, sunflower seeds, and whole grains. Supplements are useful when targeting specific support, such as pantethine for lipid-pathway support, or when food intake is limited. USDA FoodData Central. View source ↗
Will pantothenic acid interfere with my lab tests?
No. The FDA's well-known lab-interference warning is specific to biotin — pantothenic acid is not on that list and has no known lab-test interference at supplemental amounts. U.S. Food and Drug Administration. Biotin may interfere with lab tests. FDA Safety Communication. View source ↗
Does B5 really help with skin?
Topical dexpanthenol is widely used in skin and hair products and is generally well-tolerated. For oral high-amount calcium pantothenate aimed at skin appearance, the published evidence is early — a single small randomized study with positive findings, but independent replication is what would change the picture. Yang M et al. A randomized, double-blind, placebo-controlled study of a novel pantothenic acid-based dietary supplement in subjects with mild to moderate facial acne. Dermatol Ther. View source ↗
Can I take B5 during pregnancy or while nursing?
Food amounts and the B5 in a standard prenatal vitamin are well-tolerated. Higher amounts (especially pantethine) have limited published pregnancy and lactation data, so a conversation with your provider before starting a high-amount product is the right move. Sanvictores T, Chauhan S. Vitamin B5 (Pantothenic Acid). StatPearls. View source ↗
Why does B5 sometimes make people feel mildly tired even though it is sold for energy?
Mild fatigue is one of the less-expected reports with pantethine in particular. The mechanism is not established. It is uncommon, usually mild, and resolves on stopping the product. If you notice this, pausing and talking to your provider is the right next step.
10. Choosing a Quality Supplement
💡
Key Takeaway
Pick the form for your goal, look for third-party testing, check the label for the exact form (calcium pantothenate vs. pantethine vs. dexpanthenol), and avoid mega-doses without a reason.
A few practical pointers for choosing a B5 product worth your money:
Identify the form on the label. "Vitamin B5" alone is not enough — look for "calcium pantothenate," "pantethine," or "dexpanthenol" so you know exactly what you are buying.
Match the form to the goal. Pantethine is the form studied for lipid-pathway support. Calcium pantothenate is the form in everyday B-complexes. Dexpanthenol is the topical (skin and hair) form.
Look for third-party testing. USP, NSF, or ConsumerLab seals are the most reliable markers of independent verification.
Avoid mega-doses without a reason. More is not more for water-soluble vitamins — the body excretes excess in urine.
Read the inactive ingredients. If you have allergies or sensitivities, the fillers matter as much as the active.
11. Your Genes & B5
💡
Key Takeaway
Two genes shape how B5 interacts with your biology: PANK2, the rate-limiting step in CoA biosynthesis, and SLC5A6, the transporter that moves B5 into cells.
Most people inherit a fully functional CoA-biosynthesis pathway and do not need to think about their genetics here. A few notable variations: Online Mendelian Inheritance in Man. PANK2 gene entry 606157. View source ↗
PANK2 — the gene for pantothenate kinase 2, the rate-limiting step in CoA biosynthesis. Genetic variation in PANK2 can disrupt normal CoA-pathway function and requires specialist supervision; this is not a self-directed supplement situation.
SLC5A6 — the gene for the Sodium-dependent Multivitamin Transporter (SMVT), which moves B5 (along with biotin and lipoate) into cells. Rare variations in SLC5A6 can affect transport efficiency. Van Vyve T et al. Sodium-dependent multivitamin transporter deficiency. View source ↗
VNN1 — the gene for pantetheinase, the enzyme that converts pantethine into cysteamine. Differences in VNN1 expression may shape individual response to pantethine. Naumann J et al. Vanin-1 pantetheinase: a regulator of lipid metabolism. View source ↗
12. Traditional Roots
💡
Key Takeaway
Pantothenic acid is a modern science discovery, not a traditional remedy. Royal jelly — historically prized — is the richest natural source by far.
Unlike many botanicals, pantothenic acid is not a "traditional" remedy — it was identified in the 1930s as a biochemical, not used by name in older medical traditions. There is, however, a quiet historical thread: royal jelly, the bee secretion historically valued in folk and apicultural contexts, is the richest natural pantothenic acid source on Earth. Whether royal jelly's traditional reputation actually traces to its B5 content is debated — the substance has many other constituents — so this thread is best treated as background, not as evidence for a particular use.
13. Story Behind the Science
💡
Key Takeaway
Pantothenic acid was identified in 1933 by Roger Williams; its job in everyday metabolism — Coenzyme A — was worked out a generation later and earned the 1953 Nobel Prize in Medicine.
Pantothenic acid was first isolated from yeast in 1933 by Roger J. Williams, a University of Texas biochemist. Williams gave it its Greek-derived name — pantos, "from everywhere" — because the substance turned up in nearly every plant, animal, and microbe he examined.
For about two decades it was known to be essential without anyone fully understanding why. The breakthrough came in 1953 when Fritz Lipmann's laboratory worked out that pantothenic acid is built into a small carrier molecule called Coenzyme A — and that CoA is the universal acetyl-group handler in every cell in the body. Lipmann shared the Nobel Prize in Medicine that year for the discovery.
The 4'-phosphopantetheine "arm" of Acyl Carrier Protein — the cellular machinery that builds new fatty acids — was characterized in the 1960s and 1970s. Today, pantothenic acid sits at the intersection of energy biochemistry, lipid metabolism, and acetylation reactions across nearly every body system.
14. Blood Tests
💡
Key Takeaway
Pantothenic acid status testing is rarely needed in everyday care. When measured, whole-blood pantothenate and 24-hour urinary pantothenate are the research-grade options.
For most healthy adults, B5 testing is not a routine part of care — B5 status is generally good in varied diets, and meaningful low-status situations are uncommon. When B5 measurement is genuinely needed (research or specialist context), the established options are:
Whole-blood pantothenate — the most direct measure of B5 status. Available through specialty laboratories, not standard outpatient panels.
24-hour urinary pantothenate — reflects recent intake and short-term turnover.
Note that pantothenic acid does not interfere with common immunoassay-based lab tests — the well-known FDA biotin-interference warning is specific to biotin, not to other B vitamins. U.S. Food and Drug Administration. Biotin may interfere with lab tests. FDA Safety Communication. View source ↗
✓ Last Reviewed: June 2026
Pantothenic Acid (Vitamin B5)
Clinical Reference — Technical Data
1. Chemical Identity & Forms
💡
Key Takeaway
Three structurally distinct forms with non-interchangeable evidence bases: calcium pantothenate (the standard nutritional form), pantethine (cysteamine-generating disulfide form), dexpanthenol (topical alcohol form).
Pantothenic acid is an amide of pantoic acid and β-alanine. Chemical formula: C₉H₁₇NO₅. Molecular weight: 219.24 g/mol. CAS Registry Number: 79-83-4 (D-pantothenic acid; the biologically active R-enantiomer). The L-enantiomer is biologically inactive and rarely used commercially.
Three supplemental forms appear in the consumer market, each with distinct chemistry and a distinct evidence base. Cross-extrapolation between forms is not appropriate (the data layer carries IS_MULTIFORM=True with form_studied attribution per Data Layer Schema Fix #10.4e).
Calcium pantothenate (CAS 137-08-6). Calcium salt of D-pantothenic acid. The standard supplemental form. Hygroscopic white powder; aqueous solubility ~356 g/L. GRAS for direct addition to food per 21 CFR 184.1212.
Pantethine (CAS 16816-67-4). Two pantothenamide units linked through cystamine (the cysteamine dimer). Molecular weight 554.72 g/mol. In vivo, pantethine undergoes thiol-disulfide reduction and pantetheinase (VNN1)-mediated cleavage to yield pantothenic acid + cysteamine. The cysteamine moiety is responsible for pantethine's distinct effects on lipid-pathway biology.
Dexpanthenol (CAS 81-13-0). The alcohol form (D-panthenol). Molecular weight 205.25 g/mol. Predominantly topical use. Oxidized to pantothenic acid by tissue alcohol dehydrogenase upon contact.
USP-NF monograph (M11910 series) specifies identity, assay (98.0–102.0%), specific rotation (+25.0° to +27.5° for D-calcium pantothenate), heavy metals, and water content. Pharmacopeial-grade material is the standard for supplement manufacturing.
USP-NF (M11910 series), Ph. Eur., JP — official monographs for calcium pantothenate, pantethine, and dexpanthenol
GRAS regulation
21 CFR 184.1212 — calcium pantothenate GRAS for direct addition to food
Specific rotation (D-calcium pantothenate)
+25.0° to +27.5° (USP)
Stability
Light- and heat-stable; pH-stable in neutral range; sensitive to extreme acid/alkali hydrolysis
2. Mechanism of Action
💡
Key Takeaway
Pantothenic acid is the metabolic precursor to Coenzyme A via a 5-step ATP-dependent pathway (PANK rate-limiting). Pantethine bypasses the early steps and additionally releases cysteamine, which modulates HMG-CoA reductase and acetyl-CoA carboxylase activity.
CoA biosynthesis — the universal pathway. Five enzymatic steps convert pantothenic acid into Coenzyme A:
Pantothenate → 4'-phosphopantothenate (catalyzed by pantothenate kinase, PANK1/2/3/4 isoforms; ATP-dependent; rate-limiting step under most physiologic conditions, with PANK2 the mitochondrial isoform of clinical interest in PANK2 genetic-variation contexts).
4'-phosphopantothenate + cysteine → 4'-phosphopantothenoylcysteine (catalyzed by phosphopantothenoylcysteine synthetase, PPCS).
Decarboxylation → 4'-phosphopantetheine (catalyzed by phosphopantothenoylcysteine decarboxylase, PPCDC).
Adenylylation → dephospho-CoA (catalyzed by phosphopantetheine adenylyltransferase, PPAT/COASY N-terminal domain).
Phosphorylation → CoA (catalyzed by dephospho-CoA kinase, DPCK/COASY C-terminal domain). Leonardi R et al. Coenzyme A: back in action. Prog Lipid Res. View source ↗
4'-phosphopantetheine and Acyl Carrier Protein (ACP). An intermediate in the CoA pathway, 4'-phosphopantetheine, is also covalently attached to ACP via phosphopantetheinyl transferase. The 4'-phosphopantetheine "arm" carries growing acyl chains during fatty acid biosynthesis and polyketide assembly — an essential cellular machinery.
Pantethine-specific mechanism. Pantethine enters cells, is reduced to pantetheine, then cleaved by vanin-1 (VNN1, pantetheinase) to release pantothenic acid and cysteamine. The pantothenic acid feeds the standard CoA biosynthesis pathway. The cysteamine moiety produces the distinct lipid-pathway effects that calcium pantothenate does not: it modulates HMG-CoA reductase activity through thiol-disulfide exchange (in vitro: 80% inhibition of cholesterol synthesis in human fibroblasts at 100–200 μM), Ranganathan S et al. Pantethine inhibits cholesterol synthesis in human fibroblasts. View source ↗ and modulates acetyl-CoA carboxylase through cystamine-mediated thiol chemistry. McCarty MF. Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine. View source ↗
2A. Coenzyme Biology — CoA Biosynthesis Pathway Enzymes
Rate-limiting step; phosphorylates pantothenate to 4'-phosphopantothenate (ATP-dependent). PANK2 is the mitochondrial isoform of clinical significance in PANK2 genetic variation
Phosphopantothenoylcysteine synthetase (PPCS)
6.3.2.5
Cytosol
Condenses 4'-phosphopantothenate with cysteine to 4'-phosphopantothenoylcysteine (ATP-dependent)
Phosphopantothenoylcysteine decarboxylase (PPCDC)
4.1.1.36
Cytosol
Decarboxylates 4'-phosphopantothenoylcysteine to 4'-phosphopantetheine
Saturable sodium-coupled uptake of pantothenate, biotin, and lipoate. Subject to competitive inhibition; SLC5A6 loss-of-function disrupts uptake of all three substrates
3. Pharmacokinetics (ADME)
💡
Key Takeaway
Saturable, sodium-coupled SMVT-mediated intestinal absorption at low intake; passive diffusion dominates at higher amounts. Pantethine is rapidly cleaved enterally; circulating pantothenate is the principal post-absorptive species. Renal excretion of unmetabolized pantothenate.
Absorption. Intestinal uptake of pantothenic acid is mediated primarily by the Sodium-dependent Multivitamin Transporter (SMVT, gene SLC5A6), which co-transports pantothenate, biotin, and lipoate using the transmembrane sodium gradient. SMVT is saturable at physiologic intakes; at supplemental doses above transporter saturation, passive paracellular diffusion contributes substantively. Vadlapudi AD et al. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. View source ↗
Pantethine is largely cleaved enterally by VNN1-expressing brush-border tissue and additionally during passage; circulating pantothenate is the principal post-absorptive species after oral pantethine, with detectable but small circulating pantethine. Cysteamine generation from pantethine is largely intracellular following uptake. Naumann J et al. Vanin-1 pantetheinase: a regulator of lipid metabolism. View source ↗
Distribution. Whole-body pantothenic acid stores are modest (~2 g in adults). Highest tissue pantothenate concentrations: liver, adrenal cortex, kidney, heart, brain. Plasma pantothenate operates in the micromolar range; tissue concentrations are substantially higher. Pantethine itself does not appreciably cross the blood-brain barrier; CNS effects of pantethine supplementation are mediated by post-cleavage species (pantothenate, cysteamine), both of which are BBB-penetrant. Uchida Y et al. Quantitative targeted absolute proteomic analysis of human blood-brain barrier transporters. View source ↗
Metabolism. Pantothenic acid itself is not extensively metabolized; the metabolic fate of orally administered pantothenate is incorporation into the CoA biosynthesis pathway as substrate. CoA turnover is high relative to the available pantothenate pool; recycling of pantothenate from CoA degradation (via pantetheinase, then SMVT re-uptake) is metabolically meaningful.
Elimination. Excretion of unmetabolized pantothenate via the kidney is the principal route. Urinary pantothenate tracks recent intake; 24-hour urinary excretion is one of the established biomarkers of B5 status.
4. Organ-System & Functional Roles
💡
Key Takeaway
CoA-dependent biochemistry is pervasive across organ systems. The clinically distinctive organ-system signal at advanced tier (pantethine) is hepatic lipid handling.
System
Role
Mechanism
Hepatic
CoA-dependent acyl-CoA shuttling; β-oxidation, ketogenesis, lipogenesis; primary site of pantethine lipid-pathway action
Pantethine modulates HMG-CoA reductase and acetyl-CoA carboxylase via cysteamine-driven thiol chemistry
Adipose / lipid handling
De novo fatty acid synthesis (ACP-mediated); lipoprotein particle composition
4'-phosphopantetheine arm of ACP is the assembly site for de novo fatty acid synthesis; pantethine modulates lipoprotein composition across multiple RCTs
Adrenal
Steroidogenesis (acetyl-CoA → cholesterol → pregnenolone → downstream steroids); pantothenate is highly concentrated in adrenal cortex
CoA-dependent acetyl-group transfer steps; underlies the historical "anti-stress vitamin" framing (mechanism: routine biochemistry, not stress remedy)
Choline + acetyl-CoA → acetylcholine via choline acetyltransferase (CoA-dependent); CNS CoA biosynthesis is autonomous (BBB-impermeable for CoA itself; pantothenate crosses via SMVT)
Dermatologic
Sebum composition; keratinocyte renewal; wound-healing support
Pantothenate-influenced sebum and skin-barrier renewal; topical dexpanthenol widely used in dermatologic and wound-care formulations
Pantethine modulates platelet membrane disulfides — mechanism behind the caution flag for concurrent anticoagulant/antiplatelet agents at advanced tier
Renal
Urinary excretion of unmetabolized pantothenate; SMVT-mediated reabsorption
Renal SMVT participates in pantothenate handling; urinary pantothenate is an established status biomarker
Immune
VNN1/cysteamine pathway expression in lymphoid tissue (mechanism research, limited human data)
VNN1 expression in myeloid and lymphoid cells; cysteamine-mediated thiol modulation of cellular metabolism — emerging research area
5. Functional Dosing Tiers
💡
Key Takeaway
Three functional tiers. Baseline Nutritional Tier covers everyday CoA-pathway needs. Advanced Targeted Tier is the pantethine lipid-pathway range. Specialist-Directed Repletion is the PANK2-variation investigational range and is not a self-directed dosing tier.
Baseline Nutritional Tier. Adequate Intake (AI) per IOM 1998: 5 mg/day for adult men and women; 6 mg/day pregnancy; 7 mg/day lactation. Institute of Medicine (US). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. View source ↗ EFSA NDA Panel 2014 set similar Adequate Intake values. No Upper Limit established (IOM 1998; EFSA 2014). EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for pantothenic acid. View source ↗
Advanced Targeted Tier (pantethine, lipid-pathway support). Functional range studied in multiple randomized investigations: 600–900 mg/day in divided doses (commonly 300 mg twice daily or 300 mg three times daily); duration to mature effect approximately 8–16 weeks of consistent use. Evans M et al. Pantethine, a derivative of vitamin B5, favorably alters cholesterol in low to moderate cardiovascular risk subjects. View source ↗Rumberger JA et al. Pantethine, a derivative of vitamin B5, favorably alters total, LDL, and non-HDL cholesterol. Nutr Res. View source ↗
Specialist-Directed Repletion (PANK2 genetic-variation context). Pediatric pilot data have used pantethine at 60 mg/kg/day, titrated over four weeks from a starting amount of 20 mg/kg/day. Chang X et al. Pilot trial of pantethine in children with PANK2 mutation-related disease. Orphanet J Rare Dis 2020. View source ↗ A separate phase III investigation of fosmetpantotenate (a phosphopantothenate prodrug, distinct from both calcium pantothenate and pantethine) did not meet its primary endpoint. Klopstock T et al. Fosmetpantotenate Randomized Controlled Trial in PKAN. Movement Disorders 2021. View source ↗ This tier requires specialist supervision and is not appropriate for self-directed use.
5B. Per-Use-Context Dosing
Use Context
Form
Dose
Baseline nutritional intake — adult
Calcium pantothenate (or food)
5 mg/day (IOM AI)
Baseline — pregnancy
Calcium pantothenate (or food)
6 mg/day (IOM AI)
Baseline — lactation
Calcium pantothenate (or food)
7 mg/day (IOM AI)
Baseline — pediatric (1–3 y / 4–8 y / 9–13 y / 14–18 y)
Calcium pantothenate (or food)
2 / 3 / 4 / 5 mg/day (IOM AI age-stratified)
Advanced Targeted — lipid-pathway support
Pantethine
600–900 mg/day in divided doses (commonly 300 mg twice or three times daily) × 8–16 weeks to mature effect
2.5–5% topical cream/ointment as directed by product labeling
No Upper Limit (UL) was set by IOM 1998 or EFSA 2014 for any form of pantothenic acid at any age — the data did not support setting one.
6. Functional & Mechanistic Evidence
💡
Key Takeaway
Evidence framing across forms: state-of-evidence summary by use context, not per-trial narration. Mechanism evidence is strong; pantethine lipid-pathway evidence is moderate; PANK2 specialist context is limited and investigational.
Mechanism / function evidence — STRONG. The CoA biosynthesis pathway is biochemically among the best-characterized in mammalian metabolism. Each of the five enzymatic steps is independently confirmed across human and model-organism studies; ACP and the 4'-phosphopantetheine arm are similarly well-described.
Pantethine & lipid-pathway support — MODERATE, mature. A 28-study systematic review of randomized pantethine investigations established the consistency of direction-of-effect on lipid-pathway biomarkers across populations. McRae MP. Pantethine systematic review of randomized clinical investigations. View source ↗ A modern North-American randomized investigation reported modest direction-confirming effects on lipid biomarkers across 8- and 16-week observation. Evans M et al. 2014. View source ↗ A head-to-head Chinese multicenter investigation compared pantethine to a related CoA-pathway intervention in adults with elevated triglyceride biomarkers. Chen YQ et al. Efficacy and tolerability of coenzyme A vs pantethine for elevated lipid biomarkers. View source ↗ Magnitude varies by baseline population characteristics; direction is consistent.
Pantethine & hepatic lipid distribution — LIMITED, early. Open-label investigations have examined pantethine in adults with elevated hepatic lipid biomarkers; one biopsy-confirmed series used pantethine with a co-intervention. Osono Y et al. Pantethine effects on hepatic lipid distribution. View source ↗Tokushige K et al. Combined pantethine and probucol for hepatic steatosis. View source ↗ The evidence base is early and contains co-intervention confounds.
High-amount calcium pantothenate & dermatologic biomarkers — LIMITED, single positive study. A single randomized study at 2.2 g/day across 12 weeks reported direction-positive findings on dermatologic biomarkers. Yang M et al. View source ↗ Independent replication is what would change the picture; this remains a single positive study with no comparable replication available.
PANK2 genetic-variation context — LIMITED, investigational. A pediatric pilot (n=15) has investigated pantethine at advanced amounts under specialist supervision. Chang X et al. Pilot trial of pantethine in children with PANK2 mutation-related disease. Orphanet J Rare Dis 2020. View source ↗ A separate phase III investigation of fosmetpantotenate (a phosphopantothenate prodrug intervention, distinct from both calcium pantothenate and pantethine) did not meet its primary objective. Klopstock T et al. Fosmetpantotenate Randomized Controlled Trial in PKAN. Movement Disorders 2021. View source ↗
Earlier pantethine literature — historical context. Multiple older pantethine investigations established the direction-of-effect signal that the modern data confirm. Arsenio L et al. Effects of pantethine on cardiovascular risk profile. View source ↗Donati C et al. Pantethine in hemodialysis patients with elevated lipid biomarkers. View source ↗
7. Genetic Variations
💡
Key Takeaway
Three genes shape individual interaction with B5: PANK2 (rate-limiting CoA-pathway step; clinically significant variation under specialist supervision), SLC5A6 (SMVT transporter), VNN1 (pantethine activation).
PANK2 (gene OMIM 606157; PANK2-variation phenotype OMIM 234200). The rate-limiting step of CoA biosynthesis. Loss-of-function variation disrupts normal CoA-pathway biology; high-penetrance pediatric-onset phenotype with iron accumulation in the globus pallidus is the recognized clinical context. Specialist supervision is required; this is not a self-directed supplement situation. Online Mendelian Inheritance in Man. OMIM 234200. View source ↗OMIM PANK2 gene 606157. View source ↗Bokhari SRA. PKAN. StatPearls. View source ↗
SLC5A6 (Sodium-dependent Multivitamin Transporter, SMVT). The intestinal and BBB transporter for pantothenate, biotin, and lipoate. Rare loss-of-function variation disrupts uptake of all three substrates. Van Vyve T et al. Sodium-dependent multivitamin transporter deficiency. View source ↗ Small-molecule SMVT competitive inhibitors have been characterized in the literature as a potential mechanism of nutrient-handling interaction. Chirapu SR et al. High specificity in response of the sodium-dependent multivitamin transporter to derivatives of pantothenic acid. View source ↗
VNN1 (vanin-1, pantetheinase). The enzyme that cleaves pantetheine (the reduced form of pantethine) to release pantothenate and cysteamine. VNN1 expression is regulated by PPAR-α and is itself upstream of pantethine's lipid-pathway action. Individual variation in VNN1 expression may shape inter-individual pantethine response. Naumann J et al. Vanin-1 pantetheinase. View source ↗
8. Adverse Effects & Tolerability
💡
Key Takeaway
Among the better-tolerated B vitamins. Most adverse reports are mild gastrointestinal at advanced amounts. No Upper Limit was set by IOM 1998 or EFSA 2014 because data did not support one.
Common (advanced tier). Mild gastrointestinal upset — nausea, soft stool, occasional loose stool — reported more often at the 900 mg/day end of the pantethine advanced tier and on empty-stomach administration.
Uncommon. Mild fatigue (paradoxical to the consumer-market "energy" framing). Mechanism not established.
Rare. Mild atopic-skin reactions with pantethine; mechanism unclear, possibly cysteamine thiol-disulfide reactivity at advanced tier.
Rare. Mild ALT/AST elevation reported in head-to-head pantethine investigations but not significantly different from comparator. Discontinue at > 3× ULN.
Theoretical, mechanism-supported. Modest enhancement of bleeding tendency at advanced tier with concurrent anticoagulant or antiplatelet agents (cysteamine thiol-disulfide chemistry interacting with platelet membrane disulfides). No documented major bleeding event attributable to pantethine in the randomized literature.
More frequent at 900 mg/day end of pantethine advanced tier; reduced by taking with food and dividing doses
Mild fatigue
Uncommon
Reported with pantethine; mechanism not established; paradoxical to "energy" marketing framing
Mild skin reactions (rash, itch)
Rare
Sparse reports with pantethine; mechanism unclear; possibly cysteamine thiol-disulfide reactivity
Mild ALT/AST elevation
Rare
Reported in head-to-head pantethine investigations; not significantly different from comparator; discontinue at > 3× ULN
Theoretical enhanced bleeding tendency
Theoretical, mechanism-supported
Pantethine cysteamine thiol-disulfide chemistry on platelet membranes; no major bleeding event documented in randomized data; conservative monitoring with concurrent anticoagulant/antiplatelet at advanced tier
Mild headache
Rare
Reported sporadically; not consistently dose-related
Debourdeau 2001 case report involving combined high-amount pantothenate + biotin; mechanism unclear; not replicated
Severe adverse events
None documented
No documented severe events attributable to pantothenic acid at any published dose; no UL established by IOM or EFSA
9. Drug Interactions
💡
Key Takeaway
Two safety-relevant interactions: chelation with tetracycline-class antibiotics (separate by 2h) and additive thiol-chemistry effects with anticoagulants / antiplatelet agents at advanced tier. NIH ODS Tier 1 anchor: not known to interact at baseline nutritional tier.
Pantothenic acid is one of the safer B vitamins with respect to medication-handling interactions. NIH Office of Dietary Supplements summary: "not known to interact" at baseline nutritional amounts. NIH Office of Dietary Supplements. Pantothenic Acid Health Professional Fact Sheet. View source ↗ The safety-relevant interactions at advanced amounts are listed below.
Tetracycline-class antibiotics (chelation). Calcium pantothenate — via its calcium counter-ion — chelates tetracycline-class molecules in the gut, reducing absorption of both. Separate dosing by at least 2 hours.
Anticoagulants and antiplatelet agents (thiol chemistry, advanced tier pantethine only). Pantethine and its cysteamine metabolite engage in thiol-disulfide chemistry with platelet membrane disulfides. The mechanism is supported in vitro; no documented major bleeding event has been attributed to pantethine in randomized data. Conservative monitoring is appropriate when pantethine at advanced amounts is added to ongoing anticoagulant or antiplatelet therapy.
SMVT-substrate competition (theoretical). Pantothenic acid, biotin, and lipoate all share the SMVT transporter. Concurrent high-amount intake of one may modestly affect uptake of the others. Clinical significance is low.
A historical case report described a pleuropericardial reaction in a patient combining high-amount pantothenic acid with biotin; the mechanism is unclear and the report is single. Debourdeau P et al. Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H. View source ↗
10. Cautions & Who Should Avoid
💡
Key Takeaway
Four Block F panels organize the safety considerations: population red flags, drug-nutrient depletion data, lab interference panel, and the monitoring protocol template.
10a. Patient Population Red Flags
Patient populations requiring specific consideration before pantothenic acid supplementation. Pantothenic acid is exceptionally clean across the standard population categories at the Baseline Nutritional Tier; advanced-tier (pantethine) cautions are noted where applicable.
🟢 STANDARD Renal impairment — water-soluble vitamin; mild PK alteration in severe chronic kidney impairment; functional-tier well-tolerated; pantethine 600–1200 mg/d studied in hemodialysis patients (Donati 1986, n=31) Donati C et al. Pantethine in hemodialysis lipid hemodynamics. PMID 3516477. View source ↗
🟠 CAUTION Hepatic impairment at Advanced Targeted Tier — limited pantethine PK data in hepatic-insufficiency contexts; ALT/AST monitoring at baseline + during sustained advanced-tier use
🟠 CAUTION Pregnancy at Advanced Targeted Tier — Baseline Nutritional Tier (5 mg AI; 6 mg pregnancy AI) well-tolerated; pantethine advanced-tier has limited pregnancy PK data — conservative position is to defer advanced-tier use to non-pregnancy contexts Institute of Medicine (US). Dietary Reference Intakes 1998 (pregnancy AI 6 mg/d). View source ↗
🟠 CAUTION Lactation at Advanced Targeted Tier — Baseline Tier well-tolerated (lactation AI 7 mg/d); advanced-tier (pantethine) has limited lactation PK data; same conservative position
🟢 STANDARD Pediatric — age-stratified AI; Specialist-Directed Repletion in PANK2 variation context uses 60 mg/kg/d titrated under metabolic specialist oversight (Chang 2020, n=15) Chang X et al. PMID 32928263. View source ↗
🟢 STANDARD Geriatric (≥65 yr) — standard adult AI; elderly with limited dietary variety at risk for marginal status; routine intake reassessment recommended
🟠 CAUTION Polypharmacy with concurrent anticoagulants / antiplatelet agents at Advanced Targeted Tier (pantethine) — thiol-disulfide chemistry may modestly enhance bleeding tendency; mechanism-supported, no major bleeding event documented in randomized data; conservative monitoring appropriate
🟢 STANDARD Peri-operative — no anesthesia interaction, no platelet/coagulation effect at Baseline Nutritional Tier; continue at standard intake unless NPO; advanced-tier pantethine reasonable to pause peri-operatively as conservative measure
🟢 STANDARD Athletes (WADA-monitored) — pantothenic acid and pantethine NOT on the WADA Prohibited List; freely permitted in-competition and out-of-competition; no TUE required
Polypharmacy auto-flag: triggered at Advanced Targeted Tier (pantethine) with concurrent anticoagulant or antiplatelet agents. Not triggered for Baseline Nutritional Tier B5 intake.
10b. Drug-Nutrient Depletion Table
Medications and contexts documented to lower pantothenic acid status. Only documented mechanisms are entered as positive depletion entries; ten standard drug classes are evaluated.
Drug class
Mechanism
Magnitude
Repletion
Tetracycline-class antibiotics
Mutual chelation in the gut between calcium pantothenate and tetracyclines reduces absorption of both
Acute, dose-locally significant; reverses on separation
Separate dosing by ≥2 h; no long-term repletion needed
Mild; B5 deficit uncommon vs. other B-vitamins post-bariatric
Standard post-bariatric multivitamin (~7.5–10 mg B5) generally adequate Ganipisetti VM, Naha S. Bariatric Surgery Malnutrition Complications. StatPearls. View source ↗
Restrictive diets (extreme calorie restriction)
Reduced overall food intake; B5 is widespread in foods so deficit is uncommon unless intake very low
Mild; rare in eucaloric varied diets
Standard B-complex coverage adequate
Oral contraceptives
No documented pantothenic acid depletion
No documented effect
No intervention needed
Proton pump inhibitors (long-term)
No documented pantothenic acid depletion
No documented effect
No intervention needed
Metformin
No documented pantothenic acid depletion
No documented effect
No intervention needed
Statins
No documented pantothenic acid depletion
No documented effect
No intervention needed
Diuretics (thiazide, loop)
Theoretical concern for water-soluble vitamin urinary loss; not clinically documented for B5
No documented clinical depletion
No intervention needed at functional-tier B5
Glucocorticoids (long-term)
No documented pantothenic acid depletion
No documented effect
No intervention needed
10c. Lab Interference Panel
Pantothenic acid lab interference is essentially NULL across the standard immunoassay categories — a sharp contrast with biotin (FDA Safety Communications 2017/2019). Pantothenate does NOT interfere with cardiac, thyroid, hormone, oncology, or viral serology immunoassays. No FDA Safety Communication has been issued for pantothenic acid lab interference.
Category
Tests
Direction
Consequence
Washout
Streptavidin-biotin immunoassays
Wide range of automated immunoassays using the biotin-streptavidin capture chemistry
NO DOCUMENTED INTERFERENCE
FDA Safety Communication scope is biotin-specific; pantothenate not implicated U.S. Food and Drug Administration. Biotin may interfere with lab tests. View source ↗
Regulatory status: NO FDA Safety Communications specific to pantothenic acid lab interference (sharp contrast with biotin 2017/2019 Safety Communications). No EMA PRAC signal review for pantothenate. Lab interference is a biotin-specific concern that does not extend to pantothenic acid.
Recommended monitoring schedule for pantothenic acid supplementation, organized by functional dose tier and form. Pantothenic acid requires less surveillance than most supplements due to its strong safety profile; advanced-tier pantethine warrants periodic lipid + liver enzyme tracking.
8 weeks: Lipid panel re-check (effect emerges over weeks)
16 weeks: Lipid panel re-check (plateau effect by 4 months per Evans 2014, McRae 2005 pooled); ALT/AST re-check
Quarterly thereafter: Lipid panel + ALT/AST if continued long-term
Red flags: ALT/AST > 3× ULN — discontinue and consult provider; new bruising/bleeding on concurrent anticoagulant/antiplatelet therapy — discontinue and consult
Baseline: Per specialist protocol (metabolic medicine, pediatric neurology)
Ongoing: Per specialist protocol — typically PKAN-Activities-of-Daily-Living scale + relevant biomarkers
Red flags: Per specialist; this is not a self-directed monitoring context
Discontinuation guidance
Pantothenic acid does not produce withdrawal effects on discontinuation. Pantethine's lipid-pathway effect dissipates over weeks to months after stopping; lipid biomarkers will drift back toward the pre-supplementation baseline. No taper required; abrupt stop is acceptable. If pantethine was paired with anticoagulant/antiplatelet therapy, no special monitoring on stopping (the thiol-chemistry signal also dissipates).
11. Nutrient Synergies
💡
Key Takeaway
Pantothenic acid's CoA-pathway role makes it a routine member of B-complex formulations. Cysteine availability is the principal nutrient consideration for pantethine. SMVT-substrate sharing (with biotin and lipoate) is generally not clinically significant.
B-complex (riboflavin, niacin, B6, biotin, folate, B12). Standard companion nutrients; the CoA-pathway and related one-carbon and energy-metabolism pathways function together in everyday biochemistry.
Cysteine availability (pantethine context). The PPCS step of CoA biosynthesis requires cysteine. Adequate dietary cysteine supports normal CoA throughput in pantethine-dependent contexts.
SMVT substrates (biotin, lipoate). Share the same intestinal transporter as pantothenate. At normal supplemental amounts, competition is not clinically meaningful; at very high amounts of one, modest competitive effects on the others are theoretical.
Coenzyme A direct supplementation. Direct oral CoA supplementation has been investigated in a head-to-head context against pantethine. Chen YQ et al. Efficacy and tolerability of coenzyme A vs pantethine. View source ↗
12. Lab Monitoring + Repletion
💡
Key Takeaway
Status biomarkers: whole-blood pantothenate (most direct) and 24-hour urinary pantothenate (recent intake). Advanced-tier pantethine monitoring: lipid panel + ALT/AST at baseline and intervals. No FDA-mandated lab-interference monitoring (distinct from biotin).
Pantothenic acid status testing is uncommon in routine outpatient care and is not part of standard nutrition panels. When measurement is warranted, the established biomarkers are:
Whole-blood pantothenate. The most direct measure of B5 status. Reference range approximately 1.6–2.7 μmol/L in healthy adults (Wittwer 1989 via IOM 1998 DRIs, when method fully releases pantothenate from CoA). Available through specialty laboratories.
24-hour urinary pantothenate. Reflects recent intake and short-term turnover. Useful for confirming intake patterns rather than long-term status.
Plasma pantothenate. Less commonly used; whole-blood is preferred because pantothenate distributes across erythrocyte and plasma compartments.
Advanced-tier pantethine monitoring panel. When pantethine at advanced amounts is part of an ongoing nutritional plan, baseline + interval monitoring of lipid biomarkers (total cholesterol, LDL-C, non-HDL-C, ApoB) at 8- and 16-week marks captures the maturing effect. Baseline ALT/AST plus interval re-check during sustained advanced-tier use is the conservative position.
Lab interference profile. Pantothenic acid is NOT an interferent in immunoassay-based testing. The biotin Safety Communication does not apply to pantothenate. U.S. Food and Drug Administration. Biotin may interfere with lab tests. View source ↗
12A. Status Biomarkers
Biomarker
Sample
Range
Direction / Notes
Whole-blood pantothenate
EDTA whole blood
~1.6–2.7 μmol/L (healthy adults; Wittwer 1989 via IOM 1998 DRIs, method-dependent)
PRIMARY status biomarker — most direct measure of B5 status; available through specialty laboratories (not in standard outpatient panels)
24-hour urinary pantothenate
24-hour urine collection
1–7 mg/day excretion reflects adequate intake
Reflects recent intake and short-term turnover; useful for confirming intake patterns rather than long-term status
Plasma pantothenate
Plasma (heparin or EDTA)
~1.0–6.0 μmol/L
Less commonly used; whole-blood preferred because pantothenate distributes across erythrocyte and plasma compartments
Lipid panel (advanced-tier pantethine monitoring)
Fasting serum/plasma
Per laboratory reference
Total cholesterol, LDL-C, non-HDL-C, ApoB at baseline + 8 weeks + 16 weeks for pantethine Advanced Targeted Tier — captures the maturing direction-consistent effect
ALT / AST
Serum
Per laboratory reference (typically < 35–40 U/L)
Baseline + during sustained Advanced Targeted Tier pantethine use; discontinue at > 3× ULN
PKAN-ADL scale
Clinical assessment
0–87 composite score
Specialist-directed PANK2-variation context only; used in Chang 2020 pilot
Per specialist protocol — typically PKAN-ADL scale, UPDRS/FM scoring per Chang 2020 design, and relevant biomarkers. Not a self-directed monitoring context.
Topical (dexpanthenol)
None required. Systemic absorption from topical use is minimal.
Discontinuation
No taper required for any tier. Pantethine lipid-pathway effect dissipates over weeks to months after stopping; lipid biomarkers drift back toward pre-supplementation baseline.
13. Traditional Medicine
💡
Key Takeaway
Pantothenic acid is a 1933 biochemical discovery, not a traditional remedy. The royal jelly historical thread reflects an unusually high B5 content but cannot be cleanly attributed to B5 alone.
Unlike botanically-derived ingredients, pantothenic acid does not appear under that name in any traditional medicinal system — it was identified in 1933 by Roger Williams as a then-novel growth factor of yeast and bacteria. Pre-1933 literature treats individual B5-rich foods (liver, royal jelly) within their food-medicine traditions, but the underlying biochemistry was unrecognized.
Royal jelly historical context. Royal jelly is the richest natural pantothenic acid source on a weight basis. Apicultural and folk traditions ascribed restorative and metabolic properties to royal jelly long before its B5 content was characterized. Modern biochemistry frames the royal jelly story in terms of its overall composition (proteins, 10-HDA, B-vitamins) rather than B5 alone; attribution of royal jelly's traditional reputation to its B5 content specifically would overreach the data.
13A. Traditional Systems
System
Context
Modern biochemistry (1933+)
Identified 1933 by Roger J. Williams (University of Texas) as a yeast growth factor; named "pantothenic" from Greek pantos ("from everywhere") because it appeared in nearly every plant, animal, and microbe examined
Coenzyme A (1953)
Fritz Lipmann's laboratory worked out that pantothenic acid is built into Coenzyme A, the universal acetyl-group handler in every cell. Nobel Prize in Medicine 1953
Acyl Carrier Protein (1960s–70s)
4'-phosphopantetheine arm of ACP characterized as the cellular machinery for fatty acid biosynthesis and polyketide assembly
Royal jelly (apicultural tradition)
Royal jelly — historically prized in apicultural and folk-restorative traditions — is the richest natural pantothenic acid source by weight (~50 mg/100 g). Attribution of royal jelly's traditional reputation specifically to B5 is debated; the substance has many other constituents (proteins, 10-HDA, B-vitamins)
Traditional Chinese Medicine
No named single-substance traditional use of pantothenic acid; B5-rich foods (royal jelly, organ meats) appear within their food-medicine traditions, but the underlying biochemistry was not characterized until the 1930s+
Ayurveda
Same as above — no named single-substance traditional use; B5-rich foods appear within their dietary-medicine traditions
14. Quality Control
💡
Key Takeaway
USP-NF pharmacopeial monographs (M11910 series) specify identity, assay, specific rotation, and heavy metals for calcium pantothenate. Third-party verification (USP, NSF, ConsumerLab) is the practical quality marker.
The U.S. Pharmacopeia and National Formulary maintains monographs for calcium pantothenate, pantethine, and dexpanthenol specifying identity, assay (98.0–102.0%), specific optical rotation (the chirally pure D-form), heavy metals (< 20 ppm), and water content. Pharmacopeial-grade material is the standard input for U.S. supplement manufacturing.
Calcium pantothenate carries a separate GRAS designation under 21 CFR 184.1212 for direct addition to food. U.S. Code of Federal Regulations. 21 CFR 184.1212 — Calcium pantothenate. View source ↗
Third-party verification markers (most reliable indicators of independent quality oversight):
USP Verified Mark — pharmacopeial identity, potency, and contamination verification
NSF International (NSF/ANSI 173 / Certified for Sport) — identity, potency, contamination, and adulterant screening
ConsumerLab Approved Quality — independent batch testing and labeling verification
Manufacturing-quality red flags: proprietary blends without per-ingredient amounts; "100% RDA" labeling without specifying the form (calcium pantothenate vs. pantethine matters); unusually high or unusually low specific-rotation declarations.
14A. Standardization
USP-NF Calcium Pantothenate (bulk)
98.0–102.0% C₉H₁₇CaN₂O₁₀ (M11910 series) U.S. Code of Federal Regulations. 21 CFR 184.1212 — Calcium pantothenate (GRAS for direct addition to food; incorporates USP specifications). View source ↗
Specific rotation (D-calcium pantothenate)
+25.0° to +27.5° (USP — confirms D-enantiomer chiral purity)
USP-NF Pantethine
Per pharmacopoeial monograph (specific identity, assay, related substances)
USP-NF Dexpanthenol
Per pharmacopoeial monograph (topical form)
Ph. Eur. Calcium Pantothenate
Official monograph; aligned with USP specifications
Finished tablets/capsules
90.0–110.0% of labeled (USP general)
Loss on drying
≤ 5.0% (calcium pantothenate; hygroscopic)
Heavy metals
≤ 20 ppm (USP); typically lower for pharm-grade
Residue on ignition
≤ 0.1% per USP monograph
Microbial contamination
USP <61> / <62> per finished-product specs
GRAS regulation
21 CFR 184.1212 — calcium pantothenate GRAS for direct human food addition
Third-party verification
USP Verified Mark, NSF International (NSF/ANSI 173 / Certified for Sport), ConsumerLab Approved Quality — most reliable independent markers
✓ Last Reviewed: June 2026
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
